出血性滋养细胞肿瘤病灶的血管内介入栓塞治疗应用评价  

The Evaluation of the Application of Interventional Therapy in the Treatment of Massive Hemorrhage in the Treatment of Gestational Trophoblast Tumor

作　　者：刘武军[1] 李焕祥[1] 马彦寿[1] 吴泽涛[1] 吕峰泉[1] 

机构地区：[1]青海省人民医院介入科,青海西宁810007

出　　处：《中外医疗》2016年第22期29-30,36,共3页China & Foreign Medical Treatment

摘　　要：目的探究出血性滋养细胞肿瘤病灶的血管内介入栓塞治疗的治疗效果及临床评价。方法该次实验方便选取80例患者,均为2010年12月—2016年3月青海省人民医院收治的出血性滋养细胞肿瘤病灶的患者,均采用血管内介入栓塞疗法,观察治疗效果。结果共有72例(90%)患者经血管内介入栓塞治疗控制滋养细胞肿瘤病灶的出血成功,1例(1.25%)死亡,7例(8.75%)患者介入治疗后再次发生大出血,转外科手术治疗成功;不良反应的发生情况:有31例(38.75%)患者发生一过性躯体疼痛,有44例(55%)患者发热。结论血管内介入栓塞治疗出血性滋养细胞肿瘤病灶的近期疗效显著。Objective To investigate the bleeding trophoblastic tumor vascular interventional embolization in the treatment of the application evaluation. Methods Convenient selection in our hospital 80 cases in December 2010 to March 2016 were bleeding in patients with trophoblastic tumor lesions, using endovascular therapy, curative effect. Results A total of 72cases（90%） patients treated by endovascular intervention embolization in the treatment of trophoblastic tumor hemorrhage was successfully, 1 cases（1.25%） patients of death, 7 cases（8.75%） patients after percutaneous coronary intervention happen again bleeding, surgical operation treatment success; the incidence of adverse reactions： 31 cases（38.75%） occurred in patients with a control In 44 cases（55%） of the patients with transient physical pain.Conclusion There was a significant short-term curative effect of endovascular embolization in the treatment of hemorrhagic trophoblast tumor.

关 键 词：血管内介入栓塞 滋养细胞肿瘤 出血 

分 类 号：R5[医药卫生—内科学]